E型肝炎診断検査の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

E型肝炎診断検査の市場動向：

世界のE型肝炎診断検査の市場規模は、2024年に5,710万米ドルと評価され、2025年から2030年にかけて4.8%のCAGRが予測されています。

E型肝炎の世界的拡大や、特に発展途上地域での蔓延が、診断検査への需要を大きく牽引しています。公衆衛生キャンペーンや情報へのアクセス向上によりE型肝炎を取り巻く意識が高まるにつれ、早期発見と治療を求める人が増えています。このような意識の高まりが診断検査の採用を後押しし、市場の拡大に寄与しています。さらに、大規模感染の予防と医療インフラの改善に重点が置かれていることも、検査技術の継続的な進歩とともに、E型肝炎診断検査市場の成長をさらに刺激しています。

さらに、高度な分子技術、迅速検査プラットフォーム、ポイントオブケア (POC) ソリューションなどの診断技術の革新は、E型肝炎の検出を大幅に強化します。遠隔地や資源に乏しい地域で迅速な結果が求められることから、POC診断への嗜好が高まっており、市場の成長をさらに後押ししています。医療システムが早期診断とタイムリーな介入を優先する中、E型肝炎診断検査市場は今後数年間で大幅に拡大する見込みです。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 E型肝炎診断検査市場：変動要因・傾向・範囲

• 市場連関の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 E型肝炎診断検査市場：種類別のビジネス分析

• 市場シェア：種類別 (2024年・2030年)
• 種類別ダッシュボード
• 市場規模の予測と動向分析：種類別 (2018～2030年)
• ELISA HEV IgM検査
• ELISA HEV IgG検査
• 迅速診断検査
• ポリメラーゼ連鎖反応 (PCR)

第5章 E型肝炎診断検査市場：最終用途別のビジネス分析

• 市場シェア：最終用途別 (2024年・2030年)
• 最終用途別ダッシュボード
• 市場規模の予測と動向分析：最終用途別 (2018～2030年)
• 病院
• 診断検査室
• 血液バンク
• その他

第6章 E型肝炎診断検査市場：地域別の推定・動向分析

• 市場シェア：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 参入企業の概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Wantai BioPharm
  • MP Biomedicals LLP
  • PerkinElmer, Inc
  • Dia.Pro Diagnostic Bioprobes srl
  • ELITechGroup
  • Primerdesign Ltd
  • F. Hoffmann-La Roche Ltd
  • Mikrogen GmbH
  • Altona Diagnostics
  • Fortress Diagnostics

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global hepatitis E diagnostic tests market, by region, 2018 - 2030 (USD Million)
• Table 4. Global hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 5. Global hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 6. North America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
• Table 7. North America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 8. North America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 9. U.S. hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 10. U.S. hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 11. Canada hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 12. Canada hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 13. Mexico hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 14. Mexico hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 15. Europe hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
• Table 16. Europe hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 17. Europe hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 18. UK hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 19. UK hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 20. Germany hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 21. Germany hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 22. France hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 23. France hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 24. Italy hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 25. Italy hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 26. Spain hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 27. Spain hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 28. Denmark hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 29. Denmark hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 30. Sweden hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 31. Sweden hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 32. Norway hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 33. Norway hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 34. Asia Pacific hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
• Table 35. Asia Pacific hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 36. Asia Pacific hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 37. Japan hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 38. Japan hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 39. China hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 40. China hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 41. India hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 42. India hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 43. Australia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 44. Australia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 45. South Korea hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 46. South Korea hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 47. Thailand hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 48. Thailand hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 49. Latin America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
• Table 50. Latin America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 51. Latin America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 52. Brazil hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 53. Brazil hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 54. Argentina hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 55. Argentina hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 56. Middle East & Africa hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
• Table 57. Middle East & Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 58. Middle East & Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 59. South Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 60. South Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 61. Saudi Arabia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 62. Saudi Arabia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 63. UAE hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 64. UAE hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
• Table 65. Kuwait hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
• Table 66. Kuwait hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Hepatitis E diagnostic tests market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Type and end use outlook (USD Million)
• Fig. 11 Competitive landscape
• Fig. 12 Hepatitis E diagnostic tests market dynamics
• Fig. 13 Hepatitis E diagnostic tests market: Porter's five forces analysis
• Fig. 14 Hepatitis E diagnostic tests market: PESTLE analysis
• Fig. 15 Hepatitis E diagnostic tests market: Type segment dashboard
• Fig. 16 Hepatitis E diagnostic tests market: Type market share analysis, 2024 & 2030
• Fig. 17 ELISA HEV IgM tests market, 2018 - 2030 (USD Million)
• Fig. 18 ELISA HEV IgG tests market, 2018 - 2030 (USD Million)
• Fig. 19 Rapid diagnostics tests market, 2018 - 2030 (USD Million)
• Fig. 20 Polymerase Chain Reaction (PCR) market, 2018 - 2030 (USD Million)
• Fig. 21 Hepatitis E diagnostic tests market: End use segment dashboard
• Fig. 22 Hepatitis E diagnostic tests market: End use market share analysis, 2024 & 2030
• Fig. 23 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 24 Diagnostics laboratories market, 2018 - 2030 (USD Million)
• Fig. 25 Blood banks market, 2018 - 2030 (USD Million)
• Fig. 26 Others market, 2018 - 2030 (USD Million)
• Fig. 27 Hepatitis E diagnostic tests market revenue, by region
• Fig. 28 Regional marketplace: Key takeaways
• Fig. 29 Regional marketplace: Key takeaways
• Fig. 30 North America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. country dynamics
• Fig. 32 U.S. hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 33 Canada country dynamics
• Fig. 34 Canada hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 35 Mexico country dynamics
• Fig. 36 Mexico hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 37 Europe hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 38 UK country dynamics
• Fig. 39 UK hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 40 Germany country dynamics
• Fig. 41 Germany hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 42 France country dynamics
• Fig. 43 France hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 44 Italy country dynamics
• Fig. 45 Italy hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 46 Spain country dynamics
• Fig. 47 Spain hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 48 Denmark country dynamics
• Fig. 49 Denmark hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 50 Sweden country dynamics
• Fig. 51 Sweden hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 52 Norway country dynamics
• Fig. 53 Norway hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 54 Asia Pacific hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 55 Japan country dynamics
• Fig. 56 Japan hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 57 China country dynamics
• Fig. 58 China hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 59 India country dynamics
• Fig. 60 India hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 61 Australia country dynamics
• Fig. 62 Australia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 63 South Korea country dynamics
• Fig. 64 South Korea hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 65 Thailand country dynamics
• Fig. 66 Thailand hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 67 Latin America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 68 Brazil country dynamics
• Fig. 69 Brazil hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 70 Argentina country dynamics
• Fig. 71 Argentina hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 72 MEA hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 73 South Africa country dynamics
• Fig. 74 South Africa hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 75 Saudi Arabia country dynamics
• Fig. 76 Saudi Arabia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 77 UAE country dynamics
• Fig. 78 UAE hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 79 Kuwait Key country dynamicss
• Fig. 80 Kuwait hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
• Fig. 81 Company categorization
• Fig. 82 Company market position analysis
• Fig. 83 Strategic framework

Hepatitis E Diagnostic Tests Market Trends:

The global hepatitis E diagnostic tests market size was valued at USD 57.1 million in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The growing prevalence of Hepatitis E globally, especially in developing regions, significantly drives the demand for diagnostic tests. As the awareness surrounding Hepatitis E increases due to public health campaigns and improved access to information, more individuals are seeking early detection and treatment. This heightened awareness is boosting the adoption of diagnostic tests, contributing to the market's expansion. Additionally, the emphasis on preventing outbreaks and improving healthcare infrastructure further stimulates the growth of the Hepatitis E diagnostic test market, with continued advancements in testing technology.

In addition, innovations in diagnostic technologies, such as advanced molecular techniques, rapid testing platforms, and point-of-care (POC) solutions, significantly enhance the detection of hepatitis E. These advancements offer faster, more accurate, cost-effective diagnostics, which are expected to increase market demand. The surge in preference for POC diagnostics, driven by the need for quick results in remote or resource-limited areas, further boosts market growth. As healthcare systems prioritize early diagnosis and timely interventions, the hepatitis E diagnostic tests market is poised for substantial expansion in the years ahead.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end-use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• ELISA HEV IgM Tests
• ELISA HEV IgG Tests
• Rapid Diagnostics Tests
• Polymerase Chain Reaction (PCR)
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Diagnostics Laboratories
• Blood Banks
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Hepatitis E Diagnostic Tests Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. ELISA HEV IgM Tests
  • 4.4.1. ELISA HEV IgM Tests Market, 2018 - 2030 (USD Million)
• 4.5. ELISA HEV IgG Tests
  • 4.5.1. ELISA HEV IgG Tests Market, 2018 - 2030 (USD Million)
• 4.6. Rapid Diagnostics Tests
  • 4.6.1. Rapid Diagnostics Tests Market, 2018 - 2030 (USD Million)
• 4.7. Polymerase Chain Reaction (PCR)
  • 4.7.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)

Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals market, 2018 - 2030 (USD Million)
• 5.5. Diagnostics Laboratories
  • 5.5.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
• 5.6. Blood Banks
  • 5.6.1. Blood Banks Market, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Denmark Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Norway Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Wantai BioPharm
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. MP Biomedicals LLP
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. PerkinElmer, Inc
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Dia.Pro Diagnostic Bioprobes srl
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. ELITechGroup
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Primerdesign Ltd
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. F. Hoffmann-La Roche Ltd
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Mikrogen GmbH
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Altona Diagnostics
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Fortress Diagnostics
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives